Pharming receives positive EMA decision on paediatric investigation plan (PIP) for leniolisib in Europe : vimarsana.com

/PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) (NASDAQ: PHAR) announces that a positive decision has been made...

Related Keywords

United States , Netherlands , United Kingdom , London , City Of , Amsterdam , Noord Holland , Susanne Embleton , Foster Mitchell Alex Shaw , Jim Polson , Anurag Relan , Paediatric Committee , Exchange Commission , Prnewswire Pharming Groupnv , European Union , European Medicines Agency , Pharming Group , Company Euronext Amsterdam , Lifespring Life Sciences Communication , Euronext Amsterdam , Paediatric Investigation Plan , Marketing Authorisation Application , Medical Officer , Orchard Therapeutics , Annual Report , Investor Relations Manager , Spring Life Sciences Communication , Allergy Clin , Rev Allergy , Pharming Groupnv ,